Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 13/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8399641 | 0.83 | — | — | |
| SCHEMBL3677071 | 0.79 | KDM4E (0.40) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL141970 | 0.78 | KDM4E (0.42) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL3682572 | 0.76 | KDM4E (0.38) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL11330514 | 0.75 | KDM4E (0.40) | KDM4EALDH1A1TSHRTDP1MEN1 | |
| SCHEMBL191379 | 0.75 | KDM4E (0.43) | KDM4EALDH1A1TSHRTDP1MEN1 | |
| SCHEMBL191380 | 0.75 | KDM4E (0.43) | KDM4EALDH1A1TSHRTDP1MEN1 | |
| SCHEMBL3682573 | 0.75 | KDM4E (0.37) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL6909707 | 0.75 | KDM4E (0.38) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL154141 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7501519-B2 | Method for producing biperiden IV | ABBOTT GMBH & CO., KG (DE) | 2009-03-10 | — | — | US | claimed |
| EP-1389188-A1 | METHOD FOR THE PRODUCTION OF BIPERIDEN II | Abbott GmbH & Co. KG (DE) | 2004-02-18 | — | — | EP | claimed |
| EP-1389193-A1 | METHOD FOR PRODUCING BIPERIDEN I | Abbott GmbH & Co. KG (DE) | 2004-02-18 | — | — | EP | claimed |
| EP-1387828-A2 | METHOD FOR PRODUCING BIPERIDEN IV | Abbott GmbH & Co. KG (DE) | 2004-02-11 | — | — | EP | claimed |
| WO-2002096874-A2 | METHOD FOR PRODUCING BIPERIDEN IV | ABBOTT GMBH & CO. KG (DE) | 2002-12-05 | — | — | WO | claimed |
| WO-2002094801-A1 | METHOD FOR PRODUCING BIPERIDEN I | ABBOTT GMBH & CO. KG (DE) | 2002-11-28 | — | — | WO | claimed |
| WO-2002094781-A1 | METHOD FOR THE PRODUCTION OF BIPERIDEN II | ABBOTT GMBH & CO. KG (DE) | 2002-11-28 | — | — | WO | claimed |
| EP-0860421-A1 | PROCESS FOR PRODUCING CYCLIC UNSATURATED ALDEHYDES | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-08-26 | — | — | EP | claimed |
| JP-9002989-A | — | — | None | — | — | JP | disclosed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-05-11 | — | — | US | disclosed |
| US-9512070-B2 | Method for producing compound containing BIS (perfluoroalkylsulfonyl) methyl group and salt thereof, and solid electrolyte membrane produced using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9512070-B2 | Method for producing compound containing BIS (perfluoroalkylsulfonyl) methyl group and salt thereof, and solid electrolyte membrane produced using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20150266816-A1 | Method for Producing Compound Containing BIS (Perfluoroalkylsulfonyl) Methyl Group and Salt Thereof, and Solid Electrolyte Membrane Produced Using Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-1149826-A2 | Ester compounds having alicyclic structure, and methods for preparing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2001-10-31 | — | — | EP | disclosed |
| US-5886234-A | USING A SOLID ACID CATALYST TO REACT AN UNSATUREATIED ALDEHYDE E.G. CROTONALDEHYDE, AND A CYCLIC CONJUGATED DIENE, E.G CYCLOPENTADIENE, CYCLOHEXA-1,3-DIENE, IN AN EFFICIENT DIELS-ALDER REACTION | IDEMITSU KOSAN CO., LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0860421-A1 | PROCESS FOR PRODUCING CYCLIC UNSATURATED ALDEHYDES | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-08-26 | — | — | EP | disclosed |
| JP-H092989-A | PRODUCTION OF CYCLIC UNSATURATED ALDEHYDE | IDEMITSU KOSAN CO LTD | 1997-01-07 | — | — | JP | disclosed |
| US-5157164-A | Diphenolic or thiophenolic norbornene compounds; Ziegler catalyst | COPOLYMER RUBBER & CHEMICAL CORP. (US) | 1992-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266816-A1 | Method for Producing Compound Containing BIS (Perfluoroalkylsulfonyl) Methyl Group and Salt Thereof, and Solid Electrolyte Membrane Produced Using Same | PFAS, FRK, AFF4 | KDM4E 1517/4885ALDH1A1 3728/4885TSHR 597/4885 |
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | KIT, TPSB2, BTD | KDM4E 2183/4885ALDH1A1 760/4885TSHR 617/4885 |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | ARCN1, ECH1, ASIC1 | KDM4E 795/4885ALDH1A1 421/4885TSHR 4509/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | KDM4E 4643/4885ALDH1A1 804/4885TSHR 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.